2026-2030年全球腎臟透析市場
市場調查報告書
商品編碼
2078142

2026-2030年全球腎臟透析市場

Global Renal Dialysis Market 2026-2030

出版日期: | 出版商: TechNavio | 英文 298 Pages | 訂單完成後即時交付

價格
簡介目錄

全球腎臟透析市場預計將從 2025 年到 2030 年成長至 490.279 億美元,預測期內複合年成長率為 5.6%。

這份關於全球腎臟透析市場的報告提供了全面的分析,包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括:全球糖尿病和高血壓盛行率的激增(這兩種疾病是末期腎臟病的主要病因);政府報銷計劃提高了患者就醫便利性和商業性可行性;以及人工智慧驅動的遠端和自動化治療管理系統的加速應用。

本次調查客觀地結合了一手和二手訊息,包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、細分市場數據及區域分析,以及供應商格局數據。此外,報告還包含歷史數據和預測數據。

市場範圍
基準年 2025
年末 2030
調查期 2026-2030
成長勢頭 加速度
2026 年同比比較 5.4%
複合年成長率 5.6%
增量 490.279億美元

本研究指出,居家照護模式的加速發展(促進了腎臟照護的去中心化)是未來幾年全球腎臟透析市場成長的主要驅動力之一。此外,系統性地將「綠色腎臟病學」框架商業化,最大限度地減少對環境的影響,以及透過官民合作關係進行策略整合以擴展專業基礎設施網路,預計也將產生顯著的市場需求。

目錄

第1章:執行摘要

第2章 Technavio 分析

  • 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
  • 輸入的重要性及差異化因素
  • 干擾因素
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場的定義
  • 市場區隔分析
  • 2025年市場規模
  • 市場展望,2025-2030年

第5章 市場規模與表現

  • 2020-2024年全球腎臟透析市場
  • 2020-2024 年最終用戶細分市場分析
  • 按類型分類的細分市場分析,2020-2024 年
  • 基於模式的細分市場分析,2020-2024 年
  • 區域區隔市場分析,2020-2024 年
  • 2020-2024年各國細分市場分析

第6章 定性分析

  • 人工智慧的影響:全球腎臟透析市場
  • 地緣政治衝突對全球腎臟透析市場的影響。

第7章:五力分析

第8章 市場區隔:依最終用戶分類

  • 比較:按最終用戶
  • 院內透析
  • 居家透析
  • 市場機會:依最終用戶分類

第9章 市場細分:依類型

  • 比較:按類型
  • 血液透析
  • 腹膜透析
  • 其他
  • 市場機會:按類型分類

第10章 市場區隔:依治療方式

  • 比較:依模態
  • 傳統血液透析
  • 短期門診血液透析
  • 夜間血液透析
  • 市場機會:依治療方式分類

第11章 客戶情況

第12章 區域情勢

  • 區域分類
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 亞洲
    • 中國
    • 日本
    • 印度
    • 韓國
    • 泰國
    • 台灣
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
  • 世界其他地區(RoW)
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • UAE
    • 阿根廷
    • 哥倫比亞
    • 土耳其
    • 以色列
  • 市場機會:按地區分類

第13章 促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第14章 競爭格局

  • 概述
  • 競爭格局
  • 中斷狀況
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 公司排名指標
  • 企業市場定位
  • Asahi Kasei Advance Corp.
  • Baxter International Inc.
  • DaVita Inc.
  • Fresenius Medical Co. KGaA
  • JMS Co. Ltd.
  • Medica SpA
  • Medtronic Plc
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • Outset Medical Inc.
  • Rockwell Medical Inc.
  • Shandong Weigao Group Medical
  • SWS Hemodialysis Care Co.
  • Toray Industries Inc.
  • US Renal Care

第16章附錄

簡介目錄
Product Code: IRTNTR43740

The global renal dialysis market is forecasted to grow by USD 49027.9 mn during 2025-2030, accelerating at a CAGR of 5.6% during the forecast period. The report on the global renal dialysis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surging global prevalence diabetes hypertension fueling end-stage renal disease, favorable government reimbursement frameworks enhancing patient access commercial viability, accelerated integration ai remote automated therapy management systems.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 20265.4%
CAGR5.6%
Incremental Value$49027.9 mn

Technavio's global renal dialysis market is segmented as below:

By End-User

  • In center dialysis
  • Home dialysis

By Type

  • Hemodialysis
  • Peritoneal
  • Others

By Modality

  • Conventional hemodialysis
  • Short daily hemodialysis
  • Nocturnal hemodialysis

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Asia
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
  • Rest of World (ROW)
  • Rest of World (ROW)

This study identifies the accelerated transition home-based modalities driving decentralized renal care delivery as one of the prime reasons driving the global renal dialysis market growth during the next few years. Also, systemic commercial integration green nephrology frameworks minimizing ecofootprint impact and strategic consolidation publicprivate partnerships expanding specialized infrastructure networks will lead to sizable demand in the market.

The report on the global renal dialysis market covers the following areas:

  • Global renal dialysis market sizing
  • Global renal dialysis market forecast
  • Global renal dialysis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global renal dialysis market vendors that include Asahi Kasei Advance Corp., B.Braun SE, Baxter International Inc., DaVita Inc., Dialife Group, Diaverum AB, Fresenius Medical Co. KGaA, JMS Co. Ltd., Medica S.p.A., Medtronic Plc, Nikkiso Co. Ltd., Nipro Corp., Outset Medical Inc., Quanta Dialysis Technologies Ltd., Rockwell Medical Inc., Satellite Healthcare Inc., Shandong Weigao Group Medical, SWS Hemodialysis Care Co., Toray Industries Inc., US Renal Care. Also, the global renal dialysis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Modality
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Renal Dialysis Market 2020 - 2024
    • Historic Market Size - Data Table on Global Renal Dialysis Market 2020 - 2024 ($ million)
  • 5.2 End-user segment analysis 2020 - 2024
    • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
  • 5.3 Type segment analysis 2020 - 2024
    • Historic Market Size - Type Segment 2020 - 2024 ($ million)
  • 5.4 Modality segment analysis 2020 - 2024
    • Historic Market Size - Modality Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on global renal dialysis market
  • 6.2 Impact of geopolitical conflicts on global renal dialysis market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by End-user

  • 8.1 Market segments
  • 8.2 Comparison by End-user
  • 8.3 In center dialysis - Market size and forecast 2025-2030
  • 8.4 Home dialysis - Market size and forecast 2025-2030
  • 8.5 Market opportunity by End-user
    • Market opportunity by End-user ($ million)

9 Market Segmentation by Type

  • 9.1 Market segments
  • 9.2 Comparison by Type
  • 9.3 Hemodialysis - Market size and forecast 2025-2030
  • 9.4 Peritoneal - Market size and forecast 2025-2030
  • 9.5 Others - Market size and forecast 2025-2030
  • 9.6 Market opportunity by Type
    • Market opportunity by Type ($ million)

10 Market Segmentation by Modality

  • 10.1 Market segments
  • 10.2 Comparison by Modality
  • 10.3 Conventional hemodialysis - Market size and forecast 2025-2030
  • 10.4 Short daily hemodialysis - Market size and forecast 2025-2030
  • 10.5 Nocturnal hemodialysis - Market size and forecast 2025-2030
  • 10.6 Market opportunity by Modality
    • Market opportunity by Modality ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Asia - Market size and forecast 2025-2030
    • 12.4.1 China - Market size and forecast 2025-2030
    • 12.4.2 Japan - Market size and forecast 2025-2030
    • 12.4.3 India - Market size and forecast 2025-2030
    • 12.4.4 South Korea - Market size and forecast 2025-2030
    • 12.4.5 Thailand - Market size and forecast 2025-2030
    • 12.4.6 Taiwan - Market size and forecast 2025-2030
  • 12.5 Europe - Market size and forecast 2025-2030
    • 12.5.1 Germany - Market size and forecast 2025-2030
    • 12.5.2 UK - Market size and forecast 2025-2030
    • 12.5.3 France - Market size and forecast 2025-2030
    • 12.5.4 Italy - Market size and forecast 2025-2030
    • 12.5.5 Spain - Market size and forecast 2025-2030
    • 12.5.6 Russia - Market size and forecast 2025-2030
  • 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
    • 12.6.1 Brazil - Market size and forecast 2025-2030
    • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.3 South Africa - Market size and forecast 2025-2030
    • 12.6.4 UAE - Market size and forecast 2025-2030
    • 12.6.5 Argentina - Market size and forecast 2025-2030
    • 12.6.6 Colombia - Market size and forecast 2025-2030
    • 12.6.7 Turkey - Market size and forecast 2025-2030
    • 12.6.8 Israel - Market size and forecast 2025-2030
  • 12.7 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Surging global prevalence diabetes hypertension fueling end-stage renal disease
    • Favorable government reimbursement frameworks enhancing patient access commercial viability
    • Accelerated integration AI remote automated therapy management systems
  • 13.2 Market challenges
    • Elevated operational costs escalated capital requirements local procurement vulnerabilities
    • Acute shortages specialized medical personnel restrictive care delivery capacities
    • Strict regulatory frameworks lengthy approval cycles retard technological integration
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Accelerated transition home-based modalities driving decentralized renal care delivery
    • Systemic commercial integration green nephrology frameworks minimizing ecofootprint impact
    • Strategic consolidation publicprivate partnerships expanding specialized infrastructure networks

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Asahi Kasei Advance Corp.
    • Asahi Kasei Advance Corp. - Overview
    • Asahi Kasei Advance Corp. - Product / Service
    • Asahi Kasei Advance Corp. - Key offerings
    • SWOT
  • 15.5 Baxter International Inc.
    • Baxter International Inc. - Overview
    • Baxter International Inc. - Business segments
    • Baxter International Inc. - Key offerings
    • Baxter International Inc. - Segment focus
    • SWOT
  • 15.6 DaVita Inc.
    • DaVita Inc. - Overview
    • DaVita Inc. - Business segments
    • DaVita Inc. - Key offerings
    • DaVita Inc. - Segment focus
    • SWOT
  • 15.7 Fresenius Medical Co. KGaA
    • Fresenius Medical Co. KGaA - Overview
    • Fresenius Medical Co. KGaA - Business segments
    • Fresenius Medical Co. KGaA - Key offerings
    • Fresenius Medical Co. KGaA - Segment focus
    • SWOT
  • 15.8 JMS Co. Ltd.
    • JMS Co. Ltd. - Overview
    • JMS Co. Ltd. - Product / Service
    • JMS Co. Ltd. - Key offerings
    • SWOT
  • 15.9 Medica S.p.A.
    • Medica S.p.A. - Overview
    • Medica S.p.A. - Product / Service
    • Medica S.p.A. - Key offerings
    • SWOT
  • 15.10 Medtronic Plc
    • Medtronic Plc - Overview
    • Medtronic Plc - Business segments
    • Medtronic Plc - Key news
    • Medtronic Plc - Key offerings
    • Medtronic Plc - Segment focus
    • SWOT
  • 15.11 Nikkiso Co. Ltd.
    • Nikkiso Co. Ltd. - Overview
    • Nikkiso Co. Ltd. - Business segments
    • Nikkiso Co. Ltd. - Key offerings
    • Nikkiso Co. Ltd. - Segment focus
    • SWOT
  • 15.12 Nipro Corp.
    • Nipro Corp. - Overview
    • Nipro Corp. - Business segments
    • Nipro Corp. - Key offerings
    • Nipro Corp. - Segment focus
    • SWOT
  • 15.13 Outset Medical Inc.
    • Outset Medical Inc. - Overview
    • Outset Medical Inc. - Product / Service
    • Outset Medical Inc. - Key offerings
    • SWOT
  • 15.14 Rockwell Medical Inc.
    • Rockwell Medical Inc. - Overview
    • Rockwell Medical Inc. - Product / Service
    • Rockwell Medical Inc. - Key offerings
    • SWOT
  • 15.15 Shandong Weigao Group Medical
    • Shandong Weigao Group Medical - Overview
    • Shandong Weigao Group Medical - Product / Service
    • Shandong Weigao Group Medical - Key offerings
    • SWOT
  • 15.16 SWS Hemodialysis Care Co.
    • SWS Hemodialysis Care Co. - Overview
    • SWS Hemodialysis Care Co. - Business segments
    • SWS Hemodialysis Care Co. - Key offerings
    • SWS Hemodialysis Care Co. - Segment focus
    • SWOT
  • 15.17 Toray Industries Inc.
    • Toray Industries Inc. - Overview
    • Toray Industries Inc. - Business segments
    • Toray Industries Inc. - Key news
    • Toray Industries Inc. - Key offerings
    • Toray Industries Inc. - Segment focus
    • SWOT
  • 15.18 US Renal Care
    • US Renal Care - Overview
    • US Renal Care - Product / Service
    • US Renal Care - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations